key: cord-0977791-ue6gvryu
authors: Chiappini, Elena; Licari, Amelia; Motisi, Marco Antonio; Manti, Sara; Marseglia, Gian Luigi; Galli, Luisa; Lionetti, Paolo
title: Gastrointestinal involvement in children with SARS‐COV‐2 infection: An overview for the pediatrician
date: 2020-11-24
journal: Pediatr Allergy Immunol
DOI: 10.1111/pai.13373
sha: b5fbb5f5184505bc95b5bb15c134cdb01167494b
doc_id: 977791
cord_uid: ue6gvryu

Gastrointestinal symptoms are common findings in children with SARS‐CoV‐2 infection. Diarrhea and vomiting have been reported in about 8%‐9% of cases, reaching more than 20% in some studies. Children with gastrointestinal involvement appear to be younger than those without, but the severity of the disease seems to be similar between the two groups of subjects. Fecal shedding in children has been reported in 20%‐30% of children and has been observed in both those with and those without overt gastrointestinal involvement. Moreover, prolonged fecal elimination, lasting several days after negativization of real‐time polymerase chain reaction assay on respiratory swabs, has been reported with variable frequency in children with SARS‐CoV‐2 infection. These observations raise the question regarding the possibility of oral‐fecal transmission and the possible role of children in spreading the infection, particularly when they appear asymptomatic or with gastrointestinal symptoms but with no respiratory involvement, as well as during their convalescent phase.

The respiratory system appears to be the main target of SARS-CoV-2; however, numerous evidence supports the fact that the gastrointestinal tract and the liver may also be involved both in children and in adults. 2 This involvement can be associated with isolated modifications of some laboratory parameters (eg, liver enzymes) or with overt symptoms. In adults, the reported incidence of diarrhea varies from 2% to 50% of cases, and the overall percentage of diarrhea was estimated to be 10.4%. In children, the available data are sparse; however, gastrointestinal symptoms, including nausea, vomiting, diarrhea, and abdominal pain, seem to occur frequently.

Diarrhea and vomiting have been reported in about 8%-9% of cases, reaching more than 20% in some studies (Table 1) . Therefore, although COVID-19 in children seems to have a milder course than in adults and respiratory symptoms are less frequently reported, the incidence of gastrointestinal symptoms is similar to that observed in adults.

Unfortunately, both in adult and pediatric studies, the characteristics of diarrhea are not usually reported, and information related to the total number of evacuations, consistency of the stools, and duration of symptoms is poor. On one study, diarrhea appeared 1 to 8 days after the onset of the disease, with a median of 3.3 days. 2 Watery diarrhea appears to be more frequently reported. Bloody diarrhea, probably associated with SARS-CoV-2 colitis, has been described only in one adult patient so far. Few adult cases of esophagitis are also reported. Some children presented with diarrhea or vomiting as the first symptom of the disease, even before or in the absence of respiratory manifestations. For example, there are some case reports of infants or older children who developed fever and diarrhea as the only or main manifestation of the disease. 3 Thus, it is currently discussed whether, in the course of an epidemic, diagnostic tests for SARS-CoV-2 in children presenting with diarrhea alone or associated with fever should be considered. 4 Furthermore, the fact that, in some cases, gastrointestinal symptoms may precede systemic and respiratory ones supports the hypothesis that the gastrointestinal system represents a possible route of viral invasion and transmission.

In adult case series, gastrointestinal symptoms have been suggested to be associated with more severe disease, but evidence is poor. In a systematic review, diarrhea was found to be more common in patients with severe forms of COVID-19 than those with the non-severe disease (5.8% vs 3.5%, respectively) and patients with diarrhea, nausea, and vomiting were more likely to develop acute respiratory distress or to require mechanical ventilation compared to patients without gastrointestinal symptoms (6.76% vs 2.08%, P = .034). However, other studies did not confirm this

In addition to respiratory symptoms, COVID-19 can present with gastrointestinal complaints in children, suggesting possible oral-fecal transmission.

Total ( finding with gastrointestinal symptoms occurring at a similar rate in patients with severe and non-severe forms. 5 The discrepancies among study results may be influenced by several factors, including the variable proportion of patients with diarrhea observed in the various studies and by the fact that some antiviral drugs, likely used in more severe cases, include diarrhea as a possible adverse event (eg, lopinavir/ritonavir). To date, a possible correlation between the presence of diarrhea and the severity of COVID-19

does not seem to be found in children. 2 In a recent Chinese study on 244 SARS-CoV-2-infected children, authors compared disease severity between 34 (13.9%) children with at least one gastrointestinal symptom (diarrhea, nausea, vomiting, abdominal pain, decreased feeding) and with those without gastrointestinal involvement. Patients with gastrointestinal symptoms were younger (14 vs 86 months; P < .05) and were more likely to have a fever on admission (70.6% vs 35.7%, P < .05), but no other significant differences were found between the two groups, including respiratory symptoms, the duration of RT-PCR positivity for SARS-CoV-2, and lung radiology findings. 6 As regards liver involvement, a modest increase in liver enzymes is well described in the pediatric population, with varying percentages among studies, ranging from 13% to 50%. In two pediatric studies reporting two datasets in Italy and China, overall including over 270 children, increased serum levels of aspartate aminotransferase (>50 U/L; 20.4%-50% of cases) were more frequently observed than increased serum levels of alanine aminotransferase (>45 U/L; 13%-35% of cases). 7 These data, together with the fact that the increase in transaminases is often associated with the increase in creatine kinase and lactic dehydrogenase serum levels, suggest that hypertransaminasemia may be an expression of myositis than liver damage in many cases. 2 However, in children, a severe increase in serum liver enzymes is considered a warning sign. This recommendation is mainly based on data obtained from adult studies that report increased serum liver enzymes being more frequent in severe COVID-19 cases (40%-60%) than in mild or asymptomatic forms (18%-25%). 2 Abnormal bilirubin levels may also occur, although to a lesser extent than increases in alanine aminotransferase and aspartate aminotransferase.

The pathogenesis of liver damage in adults is complex and related to direct viral invasion, systemic inflammation, hepatic ischemia, and hypoxia. Liver involvement may be part of multiorgan failure in the context of a multisystem inflammatory disorder. Moreover, preexisting liver disease and drug-related liver toxicity may play a role.

that SARS-CoV-2 might directly bind to these cells to dysregulate liver function. Gamma-glutamyltransferase, a biomarker for cholangiocyte injury, has been elevated in 30 (54%) of 56 patients with COVID-19 in one adult study. 8 In pediatrics, however, it should be bared in mind that severe COVID-19 forms are exceptional and in children with SARS-COV-2 infection and abnormalities in liver function tests, investigation for possible etiologies of liver or muscle damage other than SARS-COV-2 should be considered. 2

Intestinal involvement has many reasons. The angiotensin-converting enzyme 2 receptor (ACE-2) and transmembrane protease, serine 2 (TMPRSS2), are key proteins in the cellular entry process of the virus. The co-expression of these two proteins in the same cell is essential for the entry of SARS-CoV-2. 8 Further studies are needed to clarify the mechanisms underlying diarrhea and to define the correlation between respiratory and gastrointestinal symptoms. The virus also appears to alter the intestinal microbiome even when only the respiratory mucosa is involved through the regulation of the mucosal immune system (the "gut-lung axis"). 2

In several studies in pediatric and adult populations, the fecal elimination of SARS-CoV-2 was found to be prolonged for several weeks, which has led to speculating a possible fecal-oral transmission. The 

Gastrointestinal symptoms are common findings in children with SARS-CoV-2 infection. Moreover, fecal shedding in asymptomatic children and prolonged fecal elimination, lasting several days after negativization of RT-PCR on respiratory swabs, have been reported with variable frequency in children with COVID-19. All these observations raise the question regarding the role of children in spreading the infection, in particular when they appear to be asymptomatic or with gastrointestinal symptoms and no respiratory involvement, as well as during their convalescent phase.

The authors has no conflict of interest to declare.

Data curation (equal)

Supervision (equal)

Amelia Licari: Data curation (equal)

Marco Antonio Motisi: Data curation (equal)

Sara Manti: Data curation (equal)

Gian Luigi Marseglia: Conceptualization (equal)

Luisa Galli: Conceptualization (equal)

Paolo Lionetti: Conceptualization (equal)

Luisa Galli

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents

Coronavirus disease (COVID-19) and the gastrointestinal system in children

SARS-COV-2 infection in children and newborns: a systematic review

Fecal-oral transmission of Sars-Cov-2 in children: is it time to change our approach?

SARS-CoV-2 induced diarrhoea as onset symptom in patients with COVID-19

Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms

Children with Covid-19 in pediatric emergency departments in Italy

Covid-19 and the digestive system

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent faecal viral shedding

Dynamic viral SARS-CoV-2 RNA shedding in children: preliminary data and clinical consideration of Italian Regional Center